VAccination in Early and ADvanced Prostate caNCEr
Stopped COVID stopped all trials - and ADVANCE could not restart again after the pandemic
Conditions
- Intermediate Risk Prostate Cancer
- Castration-resistant Prostate Cancer
Interventions
- BIOLOGICAL: ChAdOx1-MVA 5T4 vaccine
- DRUG: Nivolumab Infusion [Opdivo]
Sponsor
University of Oxford
Collaborators